Cargando…
A Novel Mouse Model of Aminoglycoside-Induced Hyperacusis and Tinnitus
Aminoglycosides (AG) such as amikacin are commonly used in cystic fibrosis patients with opportunistic pulmonary infections including multi-drug resistant mycobacterium tuberculous and non-tuberculous mycobacterium. Unfortunately, this class of drugs is known to cause peripheral damage to the cochle...
Autores principales: | Longenecker, Ryan J., Gu, Rende, Homan, Jennifer, Kil, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530258/ https://www.ncbi.nlm.nih.gov/pubmed/33041759 http://dx.doi.org/10.3389/fnins.2020.561185 |
Ejemplares similares
-
Development of Tinnitus and Hyperacusis in a Mouse Model of Tobramycin Cochleotoxicity
por: Longenecker, Ryan J., et al.
Publicado: (2021) -
Behavioral Models of Tinnitus and Hyperacusis in Animals
por: Hayes, Sarah H., et al.
Publicado: (2014) -
Central Gain Control in Tinnitus and Hyperacusis
por: Auerbach, Benjamin D., et al.
Publicado: (2014) -
Editorial: Neuroimaging Approaches to the Study of Tinnitus and Hyperacusis
por: Chen, Qian, et al.
Publicado: (2021) -
Speech Comprehension Difficulties in Chronic Tinnitus and Its Relation to Hyperacusis
por: Vielsmeier, Veronika, et al.
Publicado: (2016)